(1 - 13 von 18
)
IDELVION Becomes First and Only Factor IX Therapy with
www.europapress.es
— ... an extended treatment regimen beyond 14 days," adds Dr.Lutz Bonacker, Senior Vice President and General Manager, Europe, CSL Behring. › notici...
EMA grants new extended dosing options for CSL Behring's ...
pharmabiz.com
— Lutz Bonacker, senior vice president and general manager for the ' Europe at CSL Behring. “We are proud to be the only company to offer a ... › News
IDELVION® Becomes First and Only Factor IX Therapy with 21-Day...
www.streetinsider.com
· Lutz Bonacker, Senior Vice President and General Manager, Europe, CSL Behring. "We are proud to be the only company to offer a product like ...
sortiert nach Relevanz / Datum